Lixte Biotechnology announces annual meeting results; all director nominees elected

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

All five director nominees (Forman, Yen, Brown, Bernards, van der Baan) elected with >653K votes for each.
Ratification of Weinberg & Company as auditor passed with 1.33M votes for, 56K against.
Advisory approval of executive compensation passed with 672K for, 40K against.
Broker non-votes totaled ~670K on director and compensation proposals; none on auditor ratification.
Annual meeting held December 19, 2024; no other business items reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.